Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Download PDF
Thromb Haemost 1999; 81(03): 467-468
DOI: 10.1055/s-0037-1614500
DOI: 10.1055/s-0037-1614500
Letters to the Editor
The Elevated Risk for Venous Thrombosis in Persons with Hyperhomocysteinemia Is not Reflected by the Endogenous Thrombin Potential
Authors
Further Information
Publication History
Received31 July 1998
Accepted after resubmission01 December 1998
Publication Date:
09 December 2017 (online)
Present addresses: G. M. J. Bos, is presently a fellow of the Dutch Cancer Foundation; D. T. S. Rijkers, Utrecht University, Faculty of Pharmaceutics, Department of Medicinal Chemistry, Utrecht, The Netherlands; M. den Heijer, Department of Internal Medicine, University of Nijmegen, Nijmegen, The Netherlands
-
References
- 1 D’Angelo A, Selhub J.. Homocysteine and thrombotic disease. Blood 1997; 90: 1-11.
- 2 Ridker PM, Hennekens CH, Selhub J, Miletich JP, Malinow MR, Stampfer MJ.. Interrelation of hyperhomocyst(e)inemia, factor V Leiden, and risk of future venous tromboembolism. Circulation 1997; 95: 1777-82.
- 3 Heijer Mden, Rosendaal FR, Blom HJ, Gerrits WBJ, Bos GMJ.. Hyper-homocysteinemia and venous thrombosis: a metaanalysis. Thromb Haemost 1998; 80: 824-7.
- 4 Hemker HC, Wielders S, Kessels H, Béguin S.. Continous registration of thrombin generation in plasma, its use for the determination of the thrombin potential. Thromb Haemost 1993; 70 (04) 617-24.
- 5 Hemker HC, Béguin S.. Thrombin generation in plasma: Its assessment via the endogenous thrombin potential. Thromb Haemost 1995; 74 (01) 134-8.
- 6 Wielders S, Mukheerje M, Michiels J, Rijkers DTS, Cambus J-P, Knebel RWC, Kakkar V, Hemker HC, Béguin S.. The routine determination of the endogenous thrombin potential, first results in different forms of hyper-and hypocoagulability. Thromb Haemost 1997; 77: 629-36.
- 7 Rotteveel RC, Roozendaal KJ, Eijsman L, Hemker HC.. The influence of oral contraceptives on the time-integral of thrombin generation (thrombin potential). Thromb Haemost 1993; 70 (06) 959-62.
- 8 Nicolaes GAF, Thomassen MCLGD, van Oerle R, Hamulyak K, Hemker HC, Tans G, Rosing J.. A prothrombinase-based assay for detection of resistance to activated protein C. Thromb Haemost 1996; 76: 404-10.
- 9 Nicolaes GAF, Thomassen MCLGD, Tans G, Rosing J, Hemker HC.. Effect of activated protein C on thrombin generation and on the thrombin potential in plasma of normal and APC-resistant individuals. Blood Coag Fibrinol 1997; 8: 28-38.
- 10 Duchemin J, Pittet JL, Tortary M, Béguin S, Gaussem P, Alhenc-Gelas M, Aiach M.. A new method based on thrombin generation inhibition to detect both protein C and Protein S deficiencies in plasma. Thromb Haemost 1994; 71: 31-338.
- 11 Rijkers DTS, Wielders SJH, Alhenc-Gelas M, Béguin S, Hemker HC.. The thrombomodulin ratio: a screening test for the protein C pathway. Thromb Haemost 1997; 77 Suppl 2251 (Abstract).
- 12 Heijer M, den IA, Brouwer GMJ, Bos HJ, Blom AP, Spaans FR Rosendaal, Thomas CMG, Haak HL, Weijermans PW, Gerrits WBJ.. Vitamin supplementation reduces blood homocysteine levels: a controlled trial in patients with venous thrombosis and healthy volunteers. Arterioscler Thromb Vasc Biol 1998; 18: 356-61.
- 13 Heijer Mden, Blom HJ, Gerrits WBJ, Rosendaal FR, Haak HL, Wijermans PW, Bos GMJ.. Is hyperhomocysteinaemia a risk factor for recurrent venous trombosis?. Lancet 1995; 345: 882-5.
- 14 Heijer Mden, Koster T, Blom HJ, Bos GMJ, Briët E, Reitsma PH, Vandenbroucke JP, Rosendaal F.. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. NEJM 1996; 334: 759-62.
- 15 Welch GN, Loscalzo J.. Mechanisms of disease: Homocysteine and atherothrombosis. NEJM 1988; 338 (15) 1042-50.
- 16 Tsai J, Wang H, Perrella MA, Yoshizumi M, Sibinga NES, Tan LC, Haber E, Hung-Tse Chang T, Schlegel R, Lee M.. Induction of cyclin a gene expression by homocysteine in vascular smooth muscle cells. J Clin Invest 1996; 97: 146-53.
- 17 Kokame K, Kato H, Miyata T.. Homocysteine-respondent genes in vascular endothelial cells identified by differential display analysis. J Biol Chem 1996; 271 (47) 29659-65.
- 18 Homocysteine Lowering Trialist Collaboration. Lowering blood homo-cysteine with folic acid based supplements: meta-analysis of randomised trials. BMJ 1998; 316: 894-8.